Table 2.
Neutrophil/Lymphocyte apoptosis and quantification of EPCs
| Groups | PMN apoptosis (%) | CD3+CD4+ apoptosis (%) | CD3+CD8+ apoptosis (%) | EPCs (cells/μl) |
|---|---|---|---|---|
| Control | 30.87 ± 1.6506228* | 13.02 ± 1.1820885* | 31.75 ± 1.5342389* | 4.502745 ± 0.4343691* |
| IH | 22.71 ± 1.4715449* | 20.65 ± 1.3066071* | 23.65 ± 1.2929295* | 7.21344 ± 0.5855154* |
| Emphysema | 19.45 ± 1.6119347* | 18.49 ± 1.6736188* | 28.42 ± 1.4482173* | 5.84597 ± 0.4310491* |
| Overlap | 8.54 ± 2.5526457* | 22.62 ± 1.5512003* | 18.42 ± 1.1583513* | 8.88927 ± 0.5854478* |
| F | 244.228 | 87.183 | 166.354 | 133.118 |
| P | 0.000 | 0.000 | 0.000 | 0.000 |
PMNs: Polymorphonuclears; EPCs: endothelial progenitor cells.
*
There is statistical difference significantly compared with other groups.